[Skip to Navigation]
Sign In
August 2016

Error in Funding Statement

JAMA Oncol. 2016;2(8):1099. doi:10.1001/jamaoncol.2016.1752

In the Original Investigation titled “Prospective Validation of Rapid Plasma Genotyping for the Detection of EGFR and KRAS Mutations in Advanced Lung Cancer,”1 published online April 7, 2016, there was an error in the funding statement. The Gallup Research Fund should be omitted, so that the statement reads as follows: This research was supported in part by the US Department of Defense, the National Cancer Institute of the National Institutes of Health (grants R01CA135257, R01CA114465, and P50CA090578), the Phi Beta Psi Sorority, the Stading-Younger Cancer Foundation, the International Association for the Study of Lung Cancer, the Canadian Institutes of Health Research, the Canadian Association of Medical Oncologists, and the Kaplan Research Fund. This article was corrected online.

Sacher  AG, Paweletz  C, Dahlberg  SE,  et al.  Prospective validation of rapid plasma genotyping as a sensitive and specific tool for guiding lung cancer care [published online April 7, 2016].  JAMA Oncol. doi:10.1001/jamaoncol.2016.0173.Google Scholar